日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting tumor suppressor gene co-mutations in EGFR-mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification

针对EGFR突变型非小细胞肺癌中的抑癌基因共突变:ACROSS2如何强化早期强化治疗的必要性

Gunturu, Krishna S; Khan, Hina; de Lima Lopes, Gilberto Jr

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

癌症患者接种两剂和三剂 COVID-19 mRNA 疫苗后发生突破性 SARS-CoV-2 感染:来自 COVID-19 和癌症联盟的回顾性观察研究

Choueiri, Toni K; Labaki, Chris; Bakouny, Ziad; Hsu, Chih-Yuan; Schmidt, Andrew L; de Lima Lopes, Gilberto Jr; Hwang, Clara; Singh, Sunny R K; Jani, Chinmay; Weissmann, Lisa B; Griffiths, Elizabeth A; Halabi, Susan; Wu, Ulysses; Berg, Stephanie; O'Connor, Timothy E; Wise-Draper, Trisha M; Panagiotou, Orestis A; Klein, Elizabeth J; Joshi, Monika; Yared, Fares; Dutra, Miriam Santos; Gatson, Na Tosha N; Blau, Sibel; Singh, Harpreet; Nanchal, Rahul; McKay, Rana R; Nonato, Taylor K; Quinn, Ryann; Rubinstein, Samuel M; Puc, Matthew; Mavromatis, Blanche H; Vikas, Praveen; Faller, Bryan; Zaren, Howard A; Del Prete, Salvatore; Russell, Karen; Reuben, Daniel Y; Accordino, Melissa K; Singh, Harpreet; Friese, Christopher R; Mishra, Sanjay; Rivera, Donna R; Shyr, Yu; Farmakiotis, Dimitrios; Warner, Jeremy L

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

黑人和白人癌症患者在新冠肺炎治疗结果方面的种族差异

Fu, Julie; Reid, Sonya A; French, Benjamin; Hennessy, Cassandra; Hwang, Clara; Gatson, Na Tosha; Duma, Narjust; Mishra, Sanjay; Nguyen, Ryan; Hawley, Jessica E; Singh, Sunny R K; Chism, David D; Venepalli, Neeta K; Warner, Jeremy L; Choueiri, Toni K; Schmidt, Andrew L; Fecher, Leslie A; Girard, Jennifer E; Bilen, Mehmet A; Ravindranathan, Deepak; Goyal, Sharad; Wise-Draper, Trisha M; Park, Cathleen; Painter, Corrie A; McGlown, Sheila M; de Lima Lopes, Gilberto Jr; Serrano, Oscar K; Shah, Dimpy P

Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer

非小细胞肺癌中KRAS突变亚型的特征分析

Judd, Julia; Abdel Karim, Nagla; Khan, Hina; Naqash, Abdul Rafeh; Baca, Yasmine; Xiu, Joanne; VanderWalde, Ari M; Mamdani, Hirva; Raez, Luis E; Nagasaka, Misako; Pai, Sachin Gopalkrishna; Socinski, Mark A; Nieva, Jorge J; Kim, Chul; Wozniak, Antoinette J; Ikpeazu, Chukwuemeka; de Lima Lopes, Gilberto Jr; Spira, Alexander I; Korn, W Michael; Kim, Edward S; Liu, Stephen V; Borghaei, Hossein

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

COVID-19 对癌症患者的临床影响 (CCC19):一项队列研究

Kuderer, Nicole M; Choueiri, Toni K; Shah, Dimpy P; Shyr, Yu; Rubinstein, Samuel M; Rivera, Donna R; Shete, Sanjay; Hsu, Chih-Yuan; Desai, Aakash; de Lima Lopes, Gilberto Jr; Grivas, Petros; Painter, Corrie A; Peters, Solange; Thompson, Michael A; Bakouny, Ziad; Batist, Gerald; Bekaii-Saab, Tanios; Bilen, Mehmet A; Bouganim, Nathaniel; Larroya, Mateo Bover; Castellano, Daniel; Del Prete, Salvatore A; Doroshow, Deborah B; Egan, Pamela C; Elkrief, Arielle; Farmakiotis, Dimitrios; Flora, Daniel; Galsky, Matthew D; Glover, Michael J; Griffiths, Elizabeth A; Gulati, Anthony P; Gupta, Shilpa; Hafez, Navid; Halfdanarson, Thorvardur R; Hawley, Jessica E; Hsu, Emily; Kasi, Anup; Khaki, Ali R; Lemmon, Christopher A; Lewis, Colleen; Logan, Barbara; Masters, Tyler; McKay, Rana R; Mesa, Ruben A; Morgans, Alicia K; Mulcahy, Mary F; Panagiotou, Orestis A; Peddi, Prakash; Pennell, Nathan A; Reynolds, Kerry; Rosen, Lane R; Rosovsky, Rachel; Salazar, Mary; Schmidt, Andrew; Shah, Sumit A; Shaya, Justin A; Steinharter, John; Stockerl-Goldstein, Keith E; Subbiah, Suki; Vinh, Donald C; Wehbe, Firas H; Weissmann, Lisa B; Wu, Julie Tsu-Yu; Wulff-Burchfield, Elizabeth; Xie, Zhuoer; Yeh, Albert; Yu, Peter P; Zhou, Alice Y; Zubiri, Leyre; Mishra, Sanjay; Lyman, Gary H; Rini, Brian I; Warner, Jeremy L

Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System

在巴西统一医疗保健体系下,采用不同的模型评估EGFR酪氨酸激酶抑制剂治疗转移性非小细胞肺癌的成本效益。

Aguiar, Pedro Jr; Roitberg, Felipe; Lopes, Gilberto Jr; Giglio, Auro Del

Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer

奥希替尼一线治疗EGFR突变晚期非小细胞肺癌患者的成本效益分析

Aguiar, Pedro N Jr; Haaland, Benjamin; Park, Wungki; San Tan, Pui; Del Giglio, Auro; de Lima Lopes, Gilberto Jr

Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations

厄洛替尼联合林西替尼(OSI-906)或安慰剂治疗未接受过化疗且携带表皮生长因子受体激活突变的非小细胞肺癌患者的II期研究

Leighl, Natasha B; Rizvi, Naiyer A; de Lima, Lopes Gilberto Jr; Arpornwirat, Wichit; Rudin, Charles M; Chiappori, Alberto A; Ahn, Myung-Ju; Chow, Laura Q M; Bazhenova, Lyudmila; Dechaphunkul, Arunee; Sunpaweravong, Patrapim; Eaton, Keith; Chen, Jihong; Medley, Sonja; Poondru, Srinivasu; Singh, Margaret; Steinberg, Joyce; Juergens, Rosalyn A; Gadgeel, Shirish M

Can biosimilars help achieve the goals of US health care reform?

生物类似药能否帮助实现美国医疗改革的目标?

Boccia, Ralph; Jacobs, Ira; Popovian, Robert; de Lima Lopes, Gilberto Jr

What patients and providers should understand about economic evaluations in oncology

患者和医疗服务提供者应该了解肿瘤学经济评价的哪些方面

de Souza, Jonas A; de Lima Lopes, Gilberto Jr